Swiss woman receives specialist treatment in Geneva as Nigerian health authorities identify another possible exposure and intensify surveillance amid a deadly Ebola outbreak across Africa. October 27, 2026
Nigeria’s first confirmed Ebola patient in more than a decade has been evacuated to Switzerland for specialist treatment, as health authorities expand contact tracing following the discovery of another person potentially exposed to the virus. The 42-year-old Swiss woman left Abuja on Monday, October 26, accompanied by her husband, a Swiss diplomat who has shown no symptoms. Although the World Health Organization initially reported that 52 contacts remained under monitoring after the couple’s departure, the Nigeria Centre for Disease Control and Prevention subsequently reported 54 primary contacts. The latest development has reinforced the need for continued surveillance despite the patient’s removal from the country.
Nigeria’s Coordinating Minister of Health and Social Welfare, Professor Muhammad Ali Pate, authorised the evacuation after medical teams stabilised the patient. He said her condition had improved considerably and that she was conscious, responsive and communicating, with laboratory results approaching normal levels. However, he warned that clinical improvement did not necessarily mean the patient was no longer infectious. Strict infection prevention protocols were therefore maintained during the transfer, which was coordinated by Nigerian and Swiss authorities with support from the WHO. The minister praised the medical professionals involved while stressing that Nigeria’s containment operations would continue after the evacuation.
Swiss authorities confirmed that the woman and her husband arrived safely on October 26 aboard a specialist medical evacuation flight operated by Swiss Air Rescue. The patient was admitted to Geneva University Hospitals, while her husband was placed in isolation at University Hospital Zurich because of his exposure. The Swiss Federal Office of Public Health said both institutions were prepared to treat highly infectious diseases while protecting healthcare workers, other patients and the public. Geneva’s health authorities also confirmed that the evacuation followed established national and international infection prevention protocols. Swiss officials said the transfer posed no risk to the general population.
The infection was confirmed in Abuja on October 20 after laboratory tests identified the Bundibugyo species of Ebola virus. According to the WHO, the woman had returned from Uganda on October 3, developed symptoms on October 7 and sought care at a private health facility on October 11. She was subsequently identified as a suspected case before laboratory confirmation. The nine-day interval between her first medical consultation and confirmed diagnosis has drawn attention to the difficulties of detecting Ebola early, particularly because initial symptoms may resemble those of malaria and other common illnesses. Investigators are examining her travel and exposure history, but the precise source of infection has not been established.
Illustrative image of Ebola preparedness and infection prevention measures. Nigeria’s response includes contact tracing, monitoring and laboratory testing.
Nigeria’s contact-tracing operation has expanded as investigators identify people who may have encountered the patient before her diagnosis. NCDC initially identified 53 contacts, including healthcare workers, domestic personnel and the patient’s husband. Following the couple’s evacuation, WHO said 52 others remained under surveillance. However, NCDC Director-General Jide Idris disclosed on October 26 that investigators had identified an additional e-hailing driver who transported the woman before she attended hospital, bringing the agency’s reported primary-contact total to 54. Idris said more than 40 contacts were being monitored in quarantine facilities, while six were isolating at home because their assessed exposure risk was lower. Three individuals who underwent repeat testing returned negative results.
The discovery has renewed attention on the importance of reconstructing the patient’s movements and identifying potentially exposed individuals. NCDC officials said investigations would extend to secondary contacts where necessary, while health workers continue monitoring those already identified for symptoms. Ebola’s incubation period can extend to 21 days, meaning that exposed individuals require follow-up even when they initially appear healthy. The agency has urged the public to cooperate with surveillance teams, report symptoms promptly and avoid spreading unverified information. Officials have also emphasised that being classified as a contact does not establish that someone is infected, and negative tests do not eliminate the need for appropriate follow-up after a possible exposure.
The Nigerian infection forms part of a wider Ebola outbreak that began in the Democratic Republic of the Congo in May 2026 and has since affected several other countries. According to U.S. Centers for Disease Control and Prevention figures dated October 25, Congo had recorded 9,964 confirmed cases and 4,841 deaths, making the outbreak one of the largest on record. Kenya had reported nine cases and two deaths, while Uganda and France had previously recorded infections linked to the regional emergency. The WHO has warned that continued transmission in Congo, together with population movement and weaknesses in surveillance, increases the difficulty of containing the disease. Health officials have called for sustained cross-border cooperation, early detection and improved access to medical care.
Archival imagery associated with Nigeria’s 2014 Ebola response, when intensive contact tracing helped contain the country’s first outbreak.
Nigeria’s current response has revived memories of the 2014 West African Ebola epidemic, when an infected traveller arrived in Lagos from Liberia and triggered an outbreak that resulted in 20 cases and eight deaths. Nigerian authorities contained the disease through aggressive contact tracing, isolation, laboratory testing and public-health coordination, leading the WHO to declare the country free of Ebola transmission on October 20, 2014. The earlier experience offers an important reference point for today’s response, particularly because the current NCDC Director-General, Jide Idris, was Lagos State’s Commissioner for Health during the 2014 emergency. The comparison highlights the value of rapid coordination while underscoring the need to respond to the circumstances of the present outbreak.
The Bundibugyo virus presents particular medical challenges because there is currently no licensed vaccine or approved virus-specific treatment for infections caused by that species. Patients receive supportive care, including treatment for dehydration and other complications, while health workers enforce strict infection prevention procedures. Ebola spreads through direct contact with the bodily fluids of infected people who are symptomatic, rather than through ordinary casual contact with healthy individuals. The WHO has encouraged affected countries to strengthen screening, surveillance and outbreak preparedness without imposing blanket restrictions on international travel or trade. These measures aim to reduce transmission while allowing essential healthcare operations and cross-border cooperation to continue.
Although the evacuated patient is no longer receiving treatment in Nigeria, authorities have made clear that the country’s public-health response remains active. WHO Regional Director for Africa Professor Mohamed Janabi said Nigeria had no known Ebola cases remaining following the couple’s departure, but cautioned that continued vigilance was essential. NCDC officials are still tracing contacts, investigating potential exposures and preparing for possible new cases. For Nigeria, the immediate challenge is ensuring that every identified contact completes the required monitoring period while investigators establish whether any transmission occurred before the patient’s isolation. The outcome will be an important test of the country’s disease surveillance capacity and its ability to build on the lessons of the 2014 outbreak.
